There is no Press for this Ticker
CSL is the one of largest global biotech companies. Products are focused on two key areas - protein science therapies such as plasma-derived immunoglobulins for the treatment of immune deficiencies and neurological conditions, in its CSL Behring division, and influenza vaccines, in its Seqirus division. CSL has a strong research and development track record. The portfolio and pipeline include non-plasma products as the company broadens its biotech scope. Originally formed in Australia as a commonwealth-owned entity, CSL now earns half its revenue in North America and a quarter in Europe.

Related Companies

TickerCompanyChg %Mkt Cap
CMXHFCSL3.61%95.4B

CSL Company Questions & Answers

Q

How do I buy CSL (CMXHF) stock?

A

You can purchase shares of CSL (OTC: CMXHF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CSL's (CMXHF) main competitors?

A

There are no as such competitors for CSL.

Q

What is the target price for CSL?

A

There is no analysis for CSL

Q

How much is CSL (CMXHF) stock ?

A

The stock price for CSL (OTC: CMXHF) is $209.76 last updated Mon Mar 01 2021 20:57:27 GMT+0000 (Coordinated Universal Time).

Q

When is the next CSL (CMXHF) dividend?

A

There are no upcoming dividends for CSL.

Q

When is CSL (OTC:CMXHF) reporting earnings?

A

There are no earnings for CSL

Q

When is the upcoming split for CMXHF?

A

There is no upcoming split for CSL.